Tevogen announced the execution of a lease agreement to expand its corporate headquarters in Warren, New Jersey, more than doubling its footprint. The expanded space will centralize cross-functional teams, including executive leadership, regulatory affairs, corporate strategy, and research and development (previously located in Philadelphia), thereby increasing operational efficiency and enhancing cross-team collaboration. The headquarters will also house Tevogen.
AITM and the Generics & Biosimilars initiative, with dedicated facilities for Tevogen.AI's growing team of data scientists and engineers as development of its proprietary AdapTcellTM and PredicTcellTM algorithms accelerates. In addition to these core initiatives, the expanded facility could provide capacity to support potential new business units as Tevogen continues to grow and diversify its portfolio. The newly leased space was formerly occupied by CAPTRUST, a national investment advisory firm with reported total client assets exceeding $1 trillion.
Tevogen is proud to continue building in this high-profile location and expresses its sincere appreciation to the building's owner, Mitsui Sumitomo Insurance Company of America, and parent company MS&AD Insurance Group Holdings Inc., for their continued support.
